PHARMACARE Stock Overview
Dar Al-Shifa Pharmaceuticals Company manufactures, markets, and distributes medicines and chemicals in West Bank and Gaza Strip.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Dar Al-Shifa Pharmaceuticals Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.35 |
| 52 Week High | US$3.35 |
| 52 Week Low | US$2.97 |
| Beta | -0.013 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 6.31% |
| 3 Year Change | 0.24% |
| 5 Year Change | -6.44% |
| Change since IPO | -22.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHARMACARE | PS Pharmaceuticals | PS Market | |
|---|---|---|---|
| 7D | 0% | -1.4% | 0.2% |
| 1Y | 6.3% | -0.3% | -16.9% |
Return vs Industry: PHARMACARE exceeded the PS Pharmaceuticals industry which returned 0.7% over the past year.
Return vs Market: PHARMACARE exceeded the PS Market which returned -8.9% over the past year.
Price Volatility
| PHARMACARE volatility | |
|---|---|
| PHARMACARE Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 3.1% |
| 10% most volatile stocks in PS Market | 5.5% |
| 10% least volatile stocks in PS Market | 1.7% |
Stable Share Price: PHARMACARE has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHARMACARE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 423 | Bassim Subhi Farah Nasr | n/a |
Dar Al-Shifa Pharmaceuticals Company manufactures, markets, and distributes medicines and chemicals in West Bank and Gaza Strip. The company offers various human medicines, such as pills, capsules, creams, and liquids, as well as veterinary treatment products. Dar Al-Shifa Pharmaceuticals Company was founded in 1986 and is headquartered in Ramallah, the Palestinian Authority.
Dar Al-Shifa Pharmaceuticals Company Fundamentals Summary
| PHARMACARE fundamental statistics | |
|---|---|
| Market cap | US$30.15m |
| Earnings (TTM) | US$4.87m |
| Revenue (TTM) | US$30.71m |
6.2x
P/E Ratio1.0x
P/S RatioIs PHARMACARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHARMACARE income statement (TTM) | |
|---|---|
| Revenue | US$30.71m |
| Cost of Revenue | US$17.62m |
| Gross Profit | US$13.09m |
| Other Expenses | US$8.23m |
| Earnings | US$4.87m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.54 |
| Gross Margin | 42.63% |
| Net Profit Margin | 15.85% |
| Debt/Equity Ratio | 74.0% |
How did PHARMACARE perform over the long term?
See historical performance and comparison